BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34177778)

  • 1. Structural and Functional Alterations in Visual Pathway After Optic Neuritis in MOG Antibody Disease: A Comparative Study With AQP4 Seropositive NMOSD.
    Gao C; Zhuo Z; Duan Y; Yao Y; Su L; Zhang X; Song T
    Front Neurol; 2021; 12():673472. PubMed ID: 34177778
    [No Abstract]   [Full Text] [Related]  

  • 2. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
    Pache F; Zimmermann H; Mikolajczak J; Schumacher S; Lacheta A; Oertel FC; Bellmann-Strobl J; Jarius S; Wildemann B; Reindl M; Waldman A; Soelberg K; Asgari N; Ringelstein M; Aktas O; Gross N; Buttmann M; Ach T; Ruprecht K; Paul F; Brandt AU;
    J Neuroinflammation; 2016 Nov; 13(1):282. PubMed ID: 27802824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China.
    Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S
    Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AQP4-IgG and MOG-IgG Related Optic Neuritis-Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis.
    Filippatou AG; Mukharesh L; Saidha S; Calabresi PA; Sotirchos ES
    Front Neurol; 2020; 11():540156. PubMed ID: 33132999
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the retinal vascular network and structure in patients with optic neuritis associated with myelin oligodendrocyte glycoprotein or aquaporin-4 antibodies: an optical coherence tomography angiography study.
    Yu J; Huang Y; Zhou L; ZhangBao J; Zong Y; Quan C; Wang M
    J Neurol; 2021 Dec; 268(12):4874-4881. PubMed ID: 34086096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China.
    Zhao G; Chen Q; Huang Y; Li Z; Sun X; Lu P; Yan S; Wang M; Tian G
    J Neurol; 2018 Jan; 265(1):33-40. PubMed ID: 29101456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microstructural visual system changes in AQP4-antibody-seropositive NMOSD.
    Oertel FC; Kuchling J; Zimmermann H; Chien C; Schmidt F; Knier B; Bellmann-Strobl J; Korn T; Scheel M; Klistorner A; Ruprecht K; Paul F; Brandt AU
    Neurol Neuroimmunol Neuroinflamm; 2017 May; 4(3):e334. PubMed ID: 28255575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations.
    Remlinger J; Bagnoud M; Meli I; Massy M; Hoepner R; Linington C; Chan A; Bennett JL; Enzmann V; Salmen A
    Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37429715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography in central nervous system demyelinating diseases related optic neuritis.
    Mekhasingharak N; Laowanapiban P; Siritho S; Satukijchai C; Prayoonwiwat N; Jitprapaikulsan J; Chirapapaisan N;
    Int J Ophthalmol; 2018; 11(10):1649-1656. PubMed ID: 30364209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
    Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
    J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retina thickness in clinically affected and unaffected eyes in patients with aquaporin-4 immunoglobulin G antibody seropositive neuromyelitis optica spectrum disorders: a systematic review and meta-analysis.
    Huang L; Wang Y; Zhang R
    J Neurol; 2023 Feb; 270(2):759-768. PubMed ID: 36355186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning.
    Sotirchos ES; Filippatou A; Fitzgerald KC; Salama S; Pardo S; Wang J; Ogbuokiri E; Cowley NJ; Pellegrini N; Murphy OC; Mealy MA; Prince JL; Levy M; Calabresi PA; Saidha S
    Mult Scler; 2020 Oct; 26(11):1360-1371. PubMed ID: 31364464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.
    Jelcic I; Hanson JVM; Lukas S; Weber KP; Landau K; Pless M; Reindl M; Weller M; Martin R; Lutterotti A; Schippling S
    J Neuroophthalmol; 2019 Mar; 39(1):3-7. PubMed ID: 30015656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients.
    Narayan RN; McCreary M; Conger D; Wang C; Greenberg BM
    Mult Scler Relat Disord; 2019 Feb; 28():86-90. PubMed ID: 30576847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients.
    Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S
    Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study.
    Stiebel-Kalish H; Lotan I; Brody J; Chodick G; Bialer O; Marignier R; Bach M; Hellmann MA
    PLoS One; 2017; 12(1):e0170847. PubMed ID: 28125740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Characteristics of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Seropositive Male Optic Neuritis in China.
    Song H; Zhou H; Yang M; Wang J; Liu H; Sun M; Xu Q; Wei S
    J Ophthalmol; 2019; 2019():4015075. PubMed ID: 31061727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic Neuritis-Independent Retinal Atrophy in Neuromyelitis Optica Spectrum Disorder.
    Filippatou AG; Vasileiou ES; He Y; Fitzgerald KC; Kalaitzidis G; Lambe J; Mealy MA; Levy M; Liu Y; Prince JL; Mowry EM; Saidha S; Calabresi PA; Sotirchos ES
    J Neuroophthalmol; 2022 Mar; 42(1):e40-e47. PubMed ID: 34108402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and prognosis of optic neuritis in Taiwan - a hospital-based cohort study.
    Lin CW; Chen WT; Lin YH; Hung K; Chen TC
    Mult Scler Relat Disord; 2023 Jul; 75():104739. PubMed ID: 37148579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.